Young Mo Kang

5.8k total citations
110 papers, 3.4k citations indexed

About

Young Mo Kang is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Young Mo Kang has authored 110 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Rheumatology, 25 papers in Immunology and 24 papers in Molecular Biology. Recurrent topics in Young Mo Kang's work include Rheumatoid Arthritis Research and Therapies (24 papers), Systemic Lupus Erythematosus Research (22 papers) and Cell Adhesion Molecules Research (12 papers). Young Mo Kang is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (24 papers), Systemic Lupus Erythematosus Research (22 papers) and Cell Adhesion Molecules Research (12 papers). Young Mo Kang collaborates with scholars based in South Korea, United States and Singapore. Young Mo Kang's co-authors include Jae Hyung Park, Dong‐Gyu Jo, Ki Young Choi, Won Kee Lee, Eon Jeong Nam, Jörg J. Goronzy, Seung Woo Han, Ick Chan Kwon, Hyewon Ko and Hwa Seung Han and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Young Mo Kang

108 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Young Mo Kang South Korea	32	1.3k	821	719	604	534	110	3.4k
Manohar Ratnam United States	31	2.8k 2.2×	1.2k 1.4×	556 0.8×	813 1.3×	1.1k 2.1×	103	5.5k
Christian A. Seemayer Switzerland	28	774 0.6×	807 1.0×	964 1.3×	163 0.3×	423 0.8×	52	2.6k
Byung-Heon Lee South Korea	38	2.5k 2.0×	182 0.2×	855 1.2×	769 1.3×	596 1.1×	128	4.8k
B A Kamen United States	28	2.1k 1.7×	1.1k 1.3×	255 0.4×	550 0.9×	660 1.2×	57	4.7k
Dominique Bihan United Kingdom	29	825 0.6×	250 0.3×	255 0.4×	582 1.0×	340 0.6×	56	2.4k
Saroja Ramanujan United States	22	776 0.6×	249 0.3×	374 0.5×	378 0.6×	463 0.9×	46	2.4k
Li Xiong China	32	1.3k 1.0×	219 0.3×	461 0.6×	246 0.4×	1.0k 2.0×	123	3.8k
Steven Weitman United States	26	1.2k 0.9×	260 0.3×	169 0.2×	472 0.8×	880 1.6×	94	3.1k
Mosaad Megahed Germany	31	833 0.6×	752 0.9×	620 0.9×	217 0.4×	473 0.9×	177	3.1k
Hao Xiong United States	29	2.0k 1.6×	233 0.3×	492 0.7×	221 0.4×	1.6k 3.0×	132	4.4k

Countries citing papers authored by Young Mo Kang

Since Specialization

Citations

This map shows the geographic impact of Young Mo Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young Mo Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young Mo Kang more than expected).

Fields of papers citing papers by Young Mo Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Young Mo Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young Mo Kang. The network helps show where Young Mo Kang may publish in the future.

Co-authorship network of co-authors of Young Mo Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Young Mo Kang. A scholar is included among the top collaborators of Young Mo Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Young Mo Kang. Young Mo Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suh, Chang‐Hee, Anne E. Hammer, Yeong Wook Song, et al.. (2023). Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo‐controlled trial in North East Asia. International Journal of Rheumatic Diseases. 27(1). e14997–e14997. 3 indexed citations

Kang, Young Mo, et al.. (2018). Sorafenib Treatment in Advanced Hepatocellular Carcinoma with Tumor Thrombus Nearly Occupying the Entire Right Atrium. 18(2). 142–145. 3 indexed citations

Joo, Young Bin, Young Mo Kang, Hyoun‐Ah Kim, et al.. (2018). Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil. International Journal of Rheumatic Diseases. 21(5). 1031–1039. 15 indexed citations

Choi, Bo Youn, Yuri Choi, Jong Sung Park, et al.. (2018). Inhibition of Notch1 induces population and suppressive activity of regulatory T cell in inflammatory arthritis. Theranostics. 8(17). 4795–4804. 23 indexed citations

Heo, Roun, Dong Gil You, Wooram Um, et al.. (2017). Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis. Biomaterials. 131. 15–26. 141 indexed citations

Shin, Kichul, Han Joo Baek, Seong Wook Kang, et al.. (2017). Pivotal factors for successful withdrawal of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients in remission or with low-disease activity. Clinical Rheumatology. 37(2). 307–314. 2 indexed citations

Kang, Jin Hee, et al.. (2017). Stepwise inhibition of T cell recruitment at post-capillary venules by orally active desulfated heparins in inflammatory arthritis. PLoS ONE. 12(4). e0176110–e0176110. 5 indexed citations

Kim, Hyoun‐Ah, Chang‐Hee Suh, Yong-Wook Park, et al.. (2016). Impact of Childbearing Decisions on Family Size of Korean Women with Systemic Lupus Erythematosus. Journal of Korean Medical Science. 31(5). 729–729. 6 indexed citations

Han, Hwa Seung, Hansang Lee, Daewoong Jung, et al.. (2016). Zwitterionic mesoporous nanoparticles with a bioresponsive gatekeeper for cancer therapy. Acta Biomaterialia. 40. 282–292. 27 indexed citations

10.

Rao, N. Vijayakameswara, Hong Yeol Yoon, Hwa Seung Han, et al.. (2015). Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment. Expert Opinion on Drug Delivery. 13(2). 239–252. 78 indexed citations

11.

Kang, Jin Hee, Seung Rim Hwang, Md. Mahmudul Alam, et al.. (2014). Intracellular delivery of desulfated heparin with bile acid conjugation alleviates T cell-mediated inflammatory arthritis via inhibition of RhoA-dependent transcellular diapedesis. Journal of Controlled Release. 183. 9–17. 9 indexed citations

12.

Lee, Hye‐Soon, Taehyeung Kim, So‐Young Bang, et al.. (2013). Ethnic specificity of lupus-associated loci identified in a genome-wide association study in Korean women. Annals of the Rheumatic Diseases. 73(6). 1240–1245. 57 indexed citations

13.

Sivasubramanian, Maharajan, Thavasyappan Thambi, V. G. Deepagan, et al.. (2013). Carboxymethyl Dextran-Cyclodextrin Conjugate as the Carrier of Doxorubicin. Journal of Nanoscience and Nanotechnology. 13(11). 7271–7278. 24 indexed citations

14.

Hwang, Seung Rim, Dong-Hyun Seo, Taslim A. Al‐Hilal, et al.. (2012). Orally active desulfated low molecular weight heparin and deoxycholic acid conjugate, 6ODS-LHbD, suppresses neovascularization and bone destruction in arthritis. Journal of Controlled Release. 163(3). 374–384. 19 indexed citations

15.

Han, Seung Woo, Sang Il Lee, Yong Wook Park, et al.. (2012). FCRL3 gene polymorphisms contribute to the radiographic severity rather than susceptibility of rheumatoid arthritis. Human Immunology. 73(5). 537–542. 15 indexed citations

16.

Kim, Wonjung, Kyoungho Suk, Young Mo Kang, et al.. (2007). Reverse signaling initiated from GITRL induces NF-κB activation through ERK in the inflammatory activation of macrophages. Molecular Immunology. 45(2). 523–533. 52 indexed citations

17.

Son, Ji Woong, Myung Hwa Chae, Jin Eun Choi, et al.. (2006). Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genetics and Cytogenetics. 169(2). 121–127. 54 indexed citations

18.

Park, Jae‐Yong, Jung Min Park, Jin Sung Jang, et al.. (2006). Caspase 9 promoter polymorphisms and risk of primary lung cancer. Human Molecular Genetics. 15(12). 1963–1971. 83 indexed citations

19.

Kim, Kyung Mee, Myung Hwa Chae, Won Kee Lee, et al.. (2006). No association between dinucleotide repeat polymorphism in intron 1 of the epidermal growth factor receptor gene EGFR and risk of lung cancer. Cancer Genetics and Cytogenetics. 172(1). 29–32. 8 indexed citations

20.

Han, Seung Woo, et al.. (2004). Successful treatment with stent angioplasty for Budd-Chiari syndrome in Beh�et?s disease. Rheumatology International. 25(3). 234–237. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact